RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 59 filers reported holding RENEO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,660,352 | +19.6% | 218,037 | +3.0% | 0.00% | – |
| Q2 2023 | $1,388,214 | +1315.5% | 211,618 | +1190.4% | 0.00% | – |
| Q1 2023 | $98,072 | +28.3% | 16,400 | -50.0% | 0.00% | – |
| Q4 2022 | $76,424 | +39.0% | 32,800 | +100.0% | 0.00% | – |
| Q3 2022 | $55,000 | +27.9% | 16,400 | 0.0% | 0.00% | – |
| Q2 2022 | $43,000 | -83.6% | 16,400 | -81.6% | 0.00% | – |
| Q1 2022 | $262,000 | -65.2% | 89,253 | +1.4% | 0.00% | – |
| Q4 2021 | $753,000 | +17.5% | 88,063 | +2.4% | 0.00% | – |
| Q3 2021 | $641,000 | +12.9% | 86,014 | +41.2% | 0.00% | – |
| Q2 2021 | $568,000 | – | 60,915 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,534,220 | $19,298,085 | 47.73% |
| NEA Management Company, LLC | 4,785,494 | $36,441,537 | 2.81% |
| Aisling Capital Management LP | 886,075 | $6,743,031 | 2.78% |
| Octagon Capital Advisors LP | 2,279,870 | $17,361,210 | 2.67% |
| Novo Holdings A/S | 3,330,377 | $25,344,169 | 1.87% |
| GREAT POINT PARTNERS LLC | 1,167,061 | $8,887,170 | 1.62% |
| Carlyle Group Inc. | 2,698,957 | $20,539,063 | 0.89% |
| Eventide Asset Management | 2,078,142 | $15,825,051 | 0.28% |
| Rock Springs Capital Management LP | 1,143,185 | $8,705,354 | 0.23% |
| First Light Asset Management, LLC | 272,317 | $2,073,694 | 0.20% |